Australian Clinical Labs Ltd (AU:ACL) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Australian Clinical Labs Ltd announced that First Sentier Investors has ceased to be a substantial holder in the company as of October 18, 2024. This change could influence investor sentiment and stock activity, making it a point of interest for market watchers. Investors may want to keep an eye on how this shift affects the company’s stock performance.
For further insights into AU:ACL stock, check out TipRanks’ Stock Analysis page.